COMP <GO>
SCLX vs ABOS // EV/EBITDA & P/E VALUATION
Scilex Holding Company (NASDAQ) VS. Acumen Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: SCLX 3
— ABOS 0
■ METRIC PARITY
LAST: $1.87 (+1.08%) • MKT CAP: $15.7M
valuation
—
LAST: $0.24 (+14.09%) • MKT CAP: $15.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SCLX VS. ABOS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SCLX | ABOS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 21.05% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -46.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | SCLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 20.9 | 20.3 | +0.60 | SCLX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.7M | $15.2M | $516.1K | SCLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SCLX REV | ABOS REV | SCLX GROSS % | ABOS GROSS % | SCLX FCF | ABOS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.3M | $346.7M | 98.0% | — | $3.7M | -$115.5M |
| FY 2024 | $56.6M | $319.2M | 98.0% | — | $19.3M | -$86.2M |
| FY 2023 | $46.7M | $171.2M | — | — | -$20.7M | -$43.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SCLX // BETA —
ABOS // BETA —